Table 1 Comparison of serum CTRP9 and APN levels and baseline characteristics of the study subjects between the cerebral infarction group and control

CTRP9 (ng/ml)

0.58 ± 0.58

0.43 ± 0.62

0.066

0.071

tAPN (μg/ml)

13.69 ± 8.50

12.05 ± 8.32

0.089

0.082

HMW (μg/ml)

13.13 ± 8.54

11.26 ± 8.35

0.070

0.066

MMW (ng/ml)

7.27 ± 5.96

7.36 ± 8.46

0.91

0.76

LMW (μg/ml)

0.71 ± 0.25

0.72 ± 0.26

1.00

0.87

Age (year)

50.80 ± 15.37

59.34 ± 15.07

 < 0.001

0.091

Male gender (%)

108(59.3)

203(75.5)

 < 0.001

0.12

Current smoking (%)

28(15.4)

87(32.3)

 < 0.001

0.20

Alcohol consumption (%)

34(18.7)

82(30.5)

 < 0.01

0.24

Family history (%)

22(12.1)

77(28.6)

 < 0.001

0.87

Systolic BP(mmHg)

127.54 ± 19.22

137.22 ± 24.15

 < 0.001

0.08

Diastolic BP(mmHg)

79.04 ± 10.66

81.61 ± 13.56

 < 0.001

0.11

Hypertension (%)

66(36.3)

171(63.6)

 < 0.001

0.67

Fasting serum glucose(mmol/L)

4.82 ± 0.73

5.17 ± 1.28

 < 0.001

0.34

Glycosylated hemoglobin (%)

5.6(0.9)

6.5(2.2)

 < 0.001

0.31

Diabetes mellitus (%)

18(9.9)

64(23.8)

 < 0.001

0.09

Atrial fibrillation (%)

4(2.2)

18(6.7)

 < 0.05

0.17

Arrhythmia (%)

17(9.3)

43(16.0)

 < 0.05

0.52

Total cholesterol (mmol/L)

4.32 ± 0.93

3.74 ± 0.98

 < 0.001

0.18

Triglyceride (mmol/L)

1.29 ± 0.71

1.30 ± 0.70

0.88

0.76

HDL cholesterol (mmol/L)

1.18 ± 0.30

1.02 ± 0.27

 < 0.001

0.25

LDL cholesterol (mmol/L)

2.32 ± 0.63

2.08 ± 0.71

 < 0.01

0.41

Hyperlipidemia (%)

67(36.8)

87(32.3)

0.33

0.51

Homocysteine(μmol/L)

11.22 ± 4.65

12.82 ± 4.48

 < 0.01

0.16

Vitamin B 12 Deficiency (%)

40(22.0)

107(39.8)

 < 0.001

0.19

Low blood folic acid (%)

66(36.3)

120(44.6)

0.08

0.18

Stenosis and occlusion of intracranial and carotid artery (%)

4(2.2)

89(33.1)

 < 0.001

0.11

Atherosclerosis (%)

67(36.8)

139(51.7)

 < 0.01

0.24

Hepatic adipose infiltration (%)

37(20.3)

30(11.2)

 < 0.01

0.13